Phenotypical and genotypical characteristics of invasive group B Streptococcus isolates in Western Sydney 2000-2005

Pathology

Volumn 39, Issue 6, 2007, Pages 589-593

  Darbar, Archie A ^a,b   Gilbert, Gwendolyn L ^a,c  

^a Western Sydney Area Health Service   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Antimicrobial susceptibility; Bloodstream; Constitutive; Group B streptococcus; Inducible; Macrolide; Resistance; Serotype

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; INCIDENCE; INFECTION CONTROL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; RECTUM CANCER; SCREENING; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 36248935696     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701684326     Document Type: Article

References (27)

1. Schuchat A. Group B Streptococcus. Lancet 1999; 353: 51-6.
2. Blancas D, Santin M, Olmo M, et al. Group B streptococcal disease in non-pregnant adults: incidence, clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis 2004; 23: 168-73.
3. Bolanos M, Canas A, Santana OE, et al. Invasive group B streptococcal disease in non-pregnant adults. Eur J Clin Microbiol Infect Dis 2001; 20: 837-9.
4. Luna V, Coates P, Eady E, et al. A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 1999; 44: 19-25.
5. Pearlman M, Pierson C, Faix R. Frequent resistance of clinical group B Streptococcus isolates to clindamycin and erythromycin. Obstet Gynecol 1998; 92: 258-61.
6. Betriu C, Culebras E, Gomez M, et al. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother 2003; 47: 1112-4.
7. de Azavedo J, McGavin M, Duncan C, et al. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 2001; 45: 3504-8.
8. National Committee on Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing 2002; M100-S12. Wayne, PA: NCCLS, 2002.
9. Heelan J, Hasenbein M, McAdam A. Resistance of group B Streptococcus to selected antibiotics including erythromycin and clindamycin. J Clin Microbiol 2004; 42: 1263-4.
10. Morales W, Dickey S, Bornick P, et al. Change in antibiotic resistance of group B Streptococcus: impact on intrapartum management. Am J Obstet Gynecol 1999; 181: 310-4.
11. Andrews J, Diekema D, Hunter S, et al. Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centres in the western hemisphere. Am J Obstet Gynecol 2000; 183: 859-62.
12. Harrison L, Elliott J, Dwyer D, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis 1998; 177: 998-1002.
13. Uh Young, Jang IH, Hwang GY, et al. Serotypes and genotypes of erythromycin resistant group B streptococci in Korea. J Clin Microbiol 2004; 42: 3306-8.
14. von Both U, Ruess M, Mueller U, et al. A serotype V clone is predominant among erythromycin resistant Streptococcus agalactiae isolates in a south western region of Germany. J Clin Microbiol 2003; 41: 2166-9.
15. Zeng X, Kong F, Wang H, Darbar A, Gilbert GL. Simultaneous detection of nine antibiotic resistance related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization. Antimicrob Agents Chemother 2006; 50: 204-9.
16. Poyart C, Jardy L, Quesne G, et al. Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 2003; 47: 794-7.
17. Weisner A, Johnson A, Lamagni T, et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 2004; 38: 1203-8.
18. Kong F, Martin D, James G, Gilbert GL. Towards a genotyping system for Streptococcus agalactiae (group B Streptococcus): use of mobile genetic elements in Australasian invasive isolates. J Med Microbiol 2003; 52: 337-44.
19. O'Sullivan MV, Cai Y, Kong F, Zeng X, Gilbert GL. Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp. J Clin Microbiol 2006; 44: 4072-6.
20. Kong F, Ma L, Gilbert GL. Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. J Med Microbiol 2005; 54: 1133-8.
21. Centres for disease control. Prevention of perinatal group B streptococcal disease, a public health perspective. MMWR Morbidity and Mortality Weekly Report 1996; 45 (RR-7): 1-24.
22. Wolter N, Smith A, Farrell D, et al. Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of Pneumococcus. Antimicrob Agents Chemother 2005; 49: 3554-7.
23. Malbruny B, Werno A, Anderson T, et al. A new phenotype of resistance to lincosamide and streptogramin A type antibiotics in Streptococcus agalactiae in New Zealand. J Antimicrob Chemother 2004; 54: 1040-4.
24. Diekema D, Andrews J, Huynh H, et al. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol 2003; 41: 2659-61.
25. Kong F, Gowan S, Martin D, James G, Gilbert GL. Serotype identification of group B streptococci by PCR and sequencing. J Clin Microbiol 2002; 40: 216-26.
26. Kong F, Gowan S, Martin D, James G, Gilbert GL. Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J Clin Microbiol 2002; 40: 620-6.
27. Kong F, Brown M, Sabananthan A, Zeng X, Gilbert GL. Multiplex PCR-based reverse line blot hybridization assay to identify 23 Streptococcus pneumoniae polysaccharide vaccine serotypes. J Clin Microbiol 2006; 44: 1887-91.